Literature DB >> 35459589

Supramolecular nanomedicines through rational design of self-assembling prodrugs.

Han Wang1, Maya Monroe1, Faith Leslie1, Charles Flexner2, Honggang Cui3.   

Abstract

Advancements in the development of nanomaterials have led to the creation of a plethora of functional constructs as drug delivery vehicles to address many dire medical needs. The emerging prodrug strategy provides an alternative solution to create nanomedicines of extreme simplicity by directly using the therapeutic agents as molecular building blocks. This Review outlines different prodrug-based drug delivery systems, highlights the advantages of the prodrug strategy for therapeutic delivery, and demonstrates how combinations of different functionalities - such as stimuli responsiveness, targeting propensity, and multidrug conjugation - can be incorporated into designed prodrug delivery systems. Furthermore, we discuss the opportunities and challenges facing this rapidly growing field.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  drug delivery; nanomedicine; prodrug

Mesh:

Substances:

Year:  2022        PMID: 35459589      PMCID: PMC9106924          DOI: 10.1016/j.tips.2022.03.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   17.638


  79 in total

Review 1.  Cellular Uptake of Nanoparticles versus Small Molecules: A Matter of Size.

Authors:  Jesús Mosquera; Isabel García; Luis M Liz-Marzán
Journal:  Acc Chem Res       Date:  2018-08-29       Impact factor: 22.384

2.  A Molecular Recognition Approach To Synthesize Nucleoside Analogue Based Multifunctional Nanoparticles for Targeted Cancer Therapy.

Authors:  Dali Wang; Bing Liu; Yuan Ma; Chenwei Wu; Quanbing Mou; Hongping Deng; Ruibin Wang; Deyue Yan; Chuan Zhang; Xinyuan Zhu
Journal:  J Am Chem Soc       Date:  2017-09-29       Impact factor: 15.419

Review 3.  Linkers: The key elements for the creation of efficient nanotherapeutics.

Authors:  Parichehr Hassanzadeh; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  J Control Release       Date:  2017-12-12       Impact factor: 9.776

4.  Stacking as a Key Property for Creating Nanoparticles with Tunable Shape: The Case of Squalenoyl-Doxorubicin.

Authors:  Julie Mougin; Semen O Yesylevskyy; Claudie Bourgaux; David Chapron; Jean-Philippe Michel; Franco Dosio; Barbara Stella; Christophe Ramseyer; Patrick Couvreur
Journal:  ACS Nano       Date:  2019-10-15       Impact factor: 15.881

5.  Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.

Authors:  Niña G Caculitan; Josefa Dela Cruz Chuh; Yong Ma; Donglu Zhang; Katherine R Kozak; Yichin Liu; Thomas H Pillow; Jack Sadowsky; Tommy K Cheung; Qui Phung; Benjamin Haley; Byoung-Chul Lee; Robert W Akita; Mark X Sliwkowski; Andrew G Polson
Journal:  Cancer Res       Date:  2017-10-18       Impact factor: 12.701

6.  Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach.

Authors:  Benoit Louage; Lutz Nuhn; Martijn D P Risseeuw; Nane Vanparijs; Ruben De Coen; Izet Karalic; Serge Van Calenbergh; Bruno G De Geest
Journal:  Angew Chem Int Ed Engl       Date:  2016-08-25       Impact factor: 15.336

Review 7.  Cancer nanomedicine: a review of recent success in drug delivery.

Authors:  Stephanie Tran; Peter-Joseph DeGiovanni; Brandon Piel; Prakash Rai
Journal:  Clin Transl Med       Date:  2017-12-11

8.  Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy.

Authors:  Feihu Wang; Dongqing Xu; Hao Su; Weijie Zhang; Xuanrong Sun; Maya K Monroe; Rami W Chakroun; Zongyuan Wang; Wenbing Dai; Richard Oh; Han Wang; Qin Fan; Fengyi Wan; Honggang Cui
Journal:  Sci Adv       Date:  2020-04-29       Impact factor: 14.136

9.  A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine.

Authors:  Jiao Feng; Sinda Lepetre-Mouelhi; Anne Gautier; Simona Mura; Catherine Cailleau; François Coudore; Michel Hamon; Patrick Couvreur
Journal:  Sci Adv       Date:  2019-02-13       Impact factor: 14.136

Review 10.  Obstacles and opportunities in a forward vision for cancer nanomedicine.

Authors:  Irene de Lázaro; David J Mooney
Journal:  Nat Mater       Date:  2021-07-05       Impact factor: 43.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.